We serve Chemical Name:2-methylpyrazole-3-carbohydrazide CAS:197079-02-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-methylpyrazole-3-carbohydrazide
CAS.NO:197079-02-0
Synonyms:1-methylpyrazole-5-carbohydrazide;1-methyl-1H-pyrazole-5-carbohydrazide
Molecular Formula:C5H8N4O
Molecular Weight:140.14300
HS Code:2933199090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:72.94000
Exact Mass:140.07000
LogP:0.11480
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1-methylpyrazole-5-carbohydrazide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-methyl-1H-pyrazole-5-carbohydrazide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-methylpyrazole-5-carbohydrazide Use and application,1-methylpyrazole-5-carbohydrazide technical grade,usp/ep/jp grade.
Related News: The travel restrictions will take effect on Tuesday, Prime Minister Chung Sye-kyun said, as the number of people testing positive for the coronavirus in South Korea increased to 15. 2-methylpyrazole-3-carbohydrazide manufacturer One key question for the fixed-duration combo is whether it can sustain remission after treatment has stopped. In the preliminary analysis of the GLOW trial, at three months after treatment ended, 51.9% of the Imbruvica-Venclexta patients had undetectable measurable residual disease (uMRD)—a stringent marker reflecting no signs of cancer—in bone marrow, versus 17.1% for the control group. The rates for peripheral blood were 54.7% and 39% for the two groups, respectively. 2-methylpyrazole-3-carbohydrazide supplier Resonant exploits its proprietary IMPaCT tumor microenvironment models and data platform to discover novel, unappreciated targets and functionally active anti-tumor antibodies for difficult to treat tumors. 2-methylpyrazole-3-carbohydrazide vendor Resonant exploits its proprietary IMPaCT tumor microenvironment models and data platform to discover novel, unappreciated targets and functionally active anti-tumor antibodies for difficult to treat tumors. 2-methylpyrazole-3-carbohydrazide factory This is particularly important in reducing overall disease burden. Moreover, this strategic decision will not only strengthen our diabetes portfolio but also help consolidate our position as the fastest-growing player in the anti-diabetes segment, Mankind Pharma Director of Marketing Sanjay Koul said in a statement.
